Habibe Kafes

Dr. Habibe Kafes

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in Biomarkers in Medicine
Verified
Journal Article
Closed access
BTBahar TEKIN TAK
Bahar TEKIN TAK
FEfirdevs aysenur ekizler
firdevs aysenur ekizler
SCSerkan Cay
Serkan Cay
HKHabibe Kafes
Habibe Kafes
ECElif Hande Ozcan Cetin
Elif Hande Ozcan Cetin
DADursun Aras
Dursun Aras
Aim: This study sought to investigate the predictive value of whole blood viscosity (WBV) to identify high-risk patients who will develop an apical thrombus during the acute phase of anterior trans...

6 October 2019 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
PDF file
BTBahar TEKIN TAK
Bahar TEKIN TAK
SCSerkan Cay
Serkan Cay
FEfirdevs aysenur ekizler
firdevs aysenur ekizler
ECElif Hande Ozcan Cetin
Elif Hande Ozcan Cetin
HPHilal Erken Pamukcu
Hilal Erken Pamukcu
DADursun Aras
Dursun Aras
Background: Fragmented QRS (fQRS) complex, with various morphology, has been recently described as a diagnostic criterion of several cardiac diseases. However, there are little data regarding the prognostic role of fQRS in peripartum cardiomyopathy (PPCM) patients. We aimed to investigate the effect of fQRS on predicting left ventricular (LV) nonrecovery in patients with peripartum cardiomyopathy (PPCM).Methods: Ninety patients (mean age: 34.7 ± 6.5 years) with the diagnosis of PPCM were analyzed retrospectively. The median follow‐up period of was 67.0 (12.0–192.0) months. Fragmented QRS was defined as the presence of various RSR’ patterns (QRS duration < 120 ms) with or without Q wave, which include an additional R wave (R’ prime) or notching of the R wave or S wave, or the presence of more than one R' (fragmentation) without typical bundle branch block. Recovery of LV function was defined as the presence of LV ejection fraction (EF) >45%.Results: Of the patients, 54 (60%) did not recover LV function at the last follow‐up visit (nonrecovery group), while 36 of the patients (40%) exhibited LV recovery (recovery group). LV ejection fraction (EF) and fQRS were identified as independent predictors of LV nonrecovery in patients with PPCM (odds ratio OR: 5.546, 95% confidence interval CI: 0.792–0.979, p = .019 and OR: 5.986, 95% CI: 1.313–11.787, p = .014, respectively).Conclusion: Our data firstly indicated that presence of fQRS was a significant predictor of LV nonrecovery in patients with PPCM. The fQRS might assist in identifying high‐risk patients.

1 January 2022 in Northern Clinics of Istanbul
Verified
Journal Article
Open access
LALale Dinc Asarcikli
Lale Dinc Asarcikli
HKHabibe Kafes
Habibe Kafes
TSTaner Sen
Taner Sen
EIEsra Gucuk Ipek
Esra Gucuk Ipek
OBOsman Beton
Osman Beton
MYMehmet Birhan Yilmaz
Mehmet Birhan Yilmaz
OBJECTIVE: Warfarin therapy has some difficulties in terms of close monitoring and dosage. This study aims to evaluate the effect of same-fixed versus different-variable physician-based monitoring of warfarin therapy on treatment quality and clinical end-points. METHODS: A total of 625 consecutive patients requiring warfarin treatment were enrolled at seven centers. INR values of the patients measured at each visit and registered to hospital database were recorded. Time in therapeutic range (TTR) was calculated using linear interpolation method (Rosendaal's method). A TTR value of >= 65% was considered as effective warfarin treatment. If a patient was evaluated by the same-fixed physician at each INR visit, was categorized into the same-physician (SP) group. In contrast, if a patient was evaluated by different-variable physicians at each INR visit, was categorized into variable physician (VP) group. Enrolled patients were followed up for bleeding and embolic events. RESULTS: One hundred and fifty-six patients (24.9%) were followed by SP group, 469 (75.1%) patients were followed by VP group. Median TTR value of the VP group was lower than that of SP group (56.2% vs. 65.1%, respectively, p=0.009). During median 25.5 months (9-36) of follow-up, minor bleeding, major bleeding and cerebral embolic event rates were higher in VP group compared to SP group (p<0.001, p=0.023, p<0.001, respectively). In multivariate analysis, INR monitoring by VP group was found to be an independent predictor of increased risk of bleeding events (OR 2.55, 95% CI 1.64-3.96, p<0.001) and embolism (OR 3.42, 95% CI 1.66-7.04, p=0.001). CONCLUSION: INR monitoring by same physician was associated with better TTR and lower rates of adverse events during followup. Hence, it is worth encouraging an SP-based outpatient follow-up system at least for where warfarin therapy is the only choice.

23 January 2020 in Journal of Ankara University Faculty of Medicine
Verified
Journal Article
Closed access
BTBahar TEKIN TAK
Bahar TEKIN TAK
FEfirdevs aysenur ekizler
firdevs aysenur ekizler
SÇSerkan Çay
Serkan Çay
HKHabibe Kafes
Habibe Kafes
EÇElif Hande Özcan Çetin
Elif Hande Özcan Çetin
DADursun Aras
Dursun Aras

1 April 2019 in Journal of Ankara University Faculty of Medicine
Verified
Journal Article
Closed access
FEfirdevs aysenur ekizler
firdevs aysenur ekizler
BTBahar TEKIN TAK
Bahar TEKIN TAK
SÇSerkan Çay
Serkan Çay
HKHabibe Kafes
Habibe Kafes
OOOzcan Ozeke
Ozcan Ozeke
STSerkan Topaloğlu
Serkan Topaloğlu

1 January 2026 in The Turkish Journal of Geriatrics
Verified
Journal Article
Open access
PDF file
HKHabibe Kafes
Habibe Kafes
BTBahar TEKIN TAK
Bahar TEKIN TAK
AEAnıl Can ERGÜN
Anıl Can ERGÜN
ÖKÖzge Çakmak Karaaslan
Özge Çakmak Karaaslan
ATAhmet Temi̇zHan
Ahmet Temi̇zHan
FEfirdevs aysenur ekizler
firdevs aysenur ekizler
Introduction: The objective of this investigation was to determine whether the systemic immune-inflammation index (SII) and pan-immune-inflammation value (PIV), which serve as comprehensive indicators of systemic inflammatory pathways, possess the prognostic capacity to identify future stent thrombosis (ST) in geriatric STEMI patients. Materials and Method: We comprehensively screened a consecutive cohort of 1,683 elderly individuals (aged 75.3 ± 6.8 years; 64.6% male) who had been treated with primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI). Stratification was performed based on the clinical manifestation of angiographically confirmed ST during follow-up. Both SII and PIV scores were computed from standard complete blood counts obtained at the time of initial clinical presentation. Results: Over an average follow-up duration of 30 ± 10 months, definite ST was documented in 104 individuals (6.2%). Patients experiencing ST exhibited distinct baseline profiles, characterized by a higher prevalence of tobacco use and hypertension, a greater frequency of early dual antiplatelet therapy (DAPT) cessation (<30 days), prolonged total stent lengths, and markedly elevated baseline high-sensitivity C-reactive protein (hs-CRP), SII, and PIV levels. In multivariable Cox proportional hazards modeling, both admission PIV and SII emerged as robust, standalone indicators of subsequent ST. Furthermore, correlation analyses demonstrated that hs-CRP levels fluctuated in tandem with both SII (r=0.342, p<0.001) and PIV (r=0.268, p<0.001) values. Conclusion: In summary, these data demonstrate that baseline immunoinflammatory indices serve as independent and highly reliable indicators of subsequent ST development within the high-risk geriatric cohort treated with primary PCI for STEMI. Keywords: Aged; Biomarkers; Inflammation; Stent; Thrombosis; ST Elevation Myocardial Infarction.